APB R2
Alternative Names: APB-R2; Long acting FSH α/β; Long-acting follicle stimulating hormone; Long-acting FSHLatest Information Update: 12 Nov 2021
At a glance
- Originator APRILBIO
- Class Fab fragments; Follicle stimulating hormones; Infertility therapies; Recombinant fusion proteins
- Mechanism of Action Follicle stimulating hormone replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Male infertility
Most Recent Events
- 12 Nov 2021 APRILBio plans a phase I trial for Male infertility in fourth quarter of 2022 (APRILBio pipeline, November 2021)
- 25 Oct 2021 Early research in Male infertility in South Korea (Parenteral), before October 2021 (APRILBIO pipeline, October 2021)